Articles mentioning both Takeda and CEO -BoardProspects

Articles mentioning both Takeda and CEO

1-10 of 10
1. François Nader, MD, Joins Moderna's Board of Directors
  
  Explore businesswire.com Dec 10 2019 BoardMoves
  
  ...tor of NPS Pharmaceuticals from 2008 until 2015, when the company was acquired by Shire. During his tenure as CEO, Dr. Nader transformed NPS Pharma into a leading global biotechnology company focused on delivering innova...
  Read Full Article
  
  Comment
  
  Mentions: Investor Relations Leadership Sanofi
2. Phathom Pharmaceuticals Announces Leadership Succession Plan and Strengthens Board of Directors with New Appointments
  
  Explore businesswire.com Sep 27 2019 BoardMoves
  
  ...he Board of Directors at Sage Therapeutics and Vanda Pharmaceuticals. Mr. Slavinsky serves as Vice President, Takeda Center for External Innovation and Head, Gastroenterology Business Development, Externalization and Spe...
  Read Full Article
  
  Comment
  
  Mentions: Leadership Succession General Motors
3. Finch Therapeutics Announces Appointment of Dr. Jo Viney and Domenic Ferrante to its Board of ...
  
  Explore businesswire.com Sep 25 2019 BoardMoves
  
  ...ical experience to identify the key microbes driving patient outcomes. Finch has a strategic partnership with Takeda to develop FIN-524, an investigational RSM product for ulcerative colitis. Finch is using a rich founda...
  Read Full Article
  
  Comment
  
  Mentions: Investment Harvard MBA
4. Aspen Technology Appoints Georgia Keresty PhD, MPH to Its Board of Directors
  
  Explore businesswire.com Apr 18 2019 BoardMoves
  
  ...aceutical industry will complement the expertise of the existing board,” commented Antonio Pietri, president, CEO and board member at Aspen Technology. About Aspen Technology Aspen Technology (AspenTech) is a leading sof...
  Read Full Article
  
  Comment
  
  Mentions: Leadership Management Independent Director
5. Takeda Pushes Back as Group Seeks to Stop $62 Billion Shire Deal
  
  Explore BNN Bloomberg Nov 6 2018 BoardNews
  
  ...Takeda, Weber said. A representative for the investors did not immediately reply to an email seeking comment. Takeda shares jumped as much as 2.6 percent in early Tokyo trading on Tuesday. While the Japanese company’s sh...
  Read Full Article
  
  Comment
  
  Mentions: Takeover acquisition Japan
6. Palleon Pharmaceuticals Appoints Lori Hu of Vertex Ventures HC to Board of Directors
  
  Explore businesswire.com Jun 21 2018 BoardMoves
  
  ...illion Series A financing from leading biotech venture investors SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures, and AbbVie Ventures. Learn more at www.palleonpharma.com. Palleon Media Contact Ten Bridge Co...
  Read Full Article
  
  Comment
  
  Mentions: Bristol-Myers Squibb MBA Vertex
7. Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne
  
  Explore CNBC.com May 29 2018 BoardMoves
  
  ...ls, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, Ultragenyx Pharmaceutical, Inc., Takeda Pharmaceutical Company Limited, Synthetic Genomics Inc., CureVac AG and Cystic Fibrosis Foundation Ther...
  Read Full Article
  
  Comment
  
  Mentions: Board of Trustees Leadership acquisition
8. Japan's Takeda Seals $62 Billion Takeover of Adderall Maker Shire
  
  Explore Business Insider May 8 2018 BoardNews
  
  ...ieves it will generate substantial cash flow, enabling the enlarged group to pay down its borrowings quickly. Takeda expects substantial cost synergies of at least $1.4 billion. Takeda said it intended to maintain its in...
  Read Full Article
  
  Comment
  
  Mentions: Takeover acquisition Japan
9. Activists to Take Center Stage as Annual Meetings Get Under Way
  
  Explore Yahoo! Finance Apr 24 2018 BoardNews
  
  .... companies last year, including Netflix Inc. In June, advertising giant WPP Plc will face shareholders after CEO Martin Sorrell stepped down amid a leak of a probe into his conduct, laying bare the company’s lack of a p...
  Read Full Article
  
  Comment
  
  Mentions: Investment Management Google
10. 'Losing direction': Allergan Investors are Unhappy After a Wild 4 Hour Takeover Drama
  
  Explore Business Insider Apr 19 2018 BoardNews
  
  ...holders, such as divestitures, combinations and acquisitions," it said in a statement. While Allergan and its CEO Saunders were once investor darlings, things took a turn for the company in September when it touted a dea...
  Read Full Article
  
  Comment
  
  Mentions: Takeover Nasdaq Japan
11. 1-10 of 10